Ikarian Capital, LLC Gossamer Bio, Inc. Call Options Transaction History

Ikarian Capital, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $1.39 Million - $2.86 Million	192,100 Added 57.43%	526,600 $6.31 Million
Q2 2022 Aug 12, 2022	BUY	$5.97 - $9.97 $733,713 - $1.23 Million	122,900 Added 58.08%	334,500 $2.8 Million
Q1 2022 May 13, 2022	BUY	$8.44 - $12.49 $97,904 - $144,884	11,600 Added 5.8%	211,600 $1.84 Million
Q4 2021 Feb 14, 2022	BUY	$10.12 - $14.07 $147,752 - $205,422	14,600 Added 7.87%	200,000 $2.26 Million
Q3 2021 Nov 15, 2021	SELL	$7.25 - $13.23 $830,850 - $1.52 Million	-114,600 Reduced 38.2%	185,400 $2.33 Million
Q1 2021 May 17, 2021	SELL	$8.63 - $10.94 $701,619 - $889,422	-81,300 Reduced 21.32%	300,000 $2.78 Million
Q4 2020 Feb 12, 2021	BUY	$8.3 - $13.59 $2.49 Million - $4.08 Million	300,000 Added 369.0%	381,300 $3.69 Million
Q3 2020 Nov 16, 2020	BUY	$11.3 - $14.75 $918,690 - $1.2 Million	81,300 New	81,300 $1.01 Million

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $80.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.